So our propulsion events still all boil down to: Will NGIO show value and spin off... because the only GNBT item is the S-1 approval, which in itself doesn’t creat value unless NGIO lists successfully.
I sure would like to see Excellagen start to even slowly ramp up over the next few months... any sign of life from the GNBT side would be welcome!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links